Dictionaries, public comments, and even an old court case that involved underwear pricing could play a role as the government appeals a ruling that sharply limits federal authority during pandemics.
Category: CDC
KHN’s ‘What the Health?’: More Covid Complications for Congress
Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.
Judge’s Ruling on the CDC Mask Mandate Highlights the Limits of the Agency’s Power
A recent court decision that overturns one of the Centers for Disease Control and Prevention’s few pandemic rules — masks required on public transportation — spotlights how little power remains in federal hands to enforce public health protections.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Babies Die as Congenital Syphilis Continues a Decade-Long Surge Across the US
Congenital syphilis rates keep climbing, according to newly released federal data. But the primary funding source for most public health departments has been largely stagnant, its purchasing power dragged even lower by inflation.
Colorado Moves Toward Statewide Coverage of Wastewater Surveillance
Colorado was among the first states to embrace wastewater testing to track the coronavirus, an important public heath intervention that can give early warning of outbreaks.
KHN’s ‘What the Health?’: Finally, a Fix for the ‘Family Glitch’
week to announce a new policy for the Affordable Care Act that would make subsidies available to more families with unaffordable employer coverage. Meanwhile, Congress struggled to find a compromise for continued federal funding of covid-19 vaccines, testing, and treatments. Tami Luhby of CNN, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Why Black and Hispanic Seniors Are Left With a Less Powerful Flu Vaccine
Federal health officials haven’t taken a clear position on whether a high-dose influenza vaccine — on the market since 2010 — is the best choice for people 65 and older. Many in that group already opt for the costlier enhanced shot. Those who get the standard vaccine are disproportionately members of ethnic and racial minorities.
Delays for Autism Diagnosis and Treatment Grew Even Longer During the Pandemic
Despite increased public awareness, research advances, and wider insurance coverage for autism therapies, children often wait months — in some cases more than a year — to get an autism diagnosis and begin intervention services. The waits can be longer for Black and Latino children, and families in rural areas are also disadvantaged, without access to providers.
